Cargando…
Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
Clostridioides difficile infection poses significant clinical challenges due to its recurrent nature. Current antibiotic management does not address the underlying issue, that of a disturbed gastrointestinal microbiome, called dysbiosis. This provides a supportive environment for the germination of...
Autores principales: | Chopra, Teena, Hecht, Gail, Tillotson, Glenn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868170/ https://www.ncbi.nlm.nih.gov/pubmed/36698844 http://dx.doi.org/10.3389/fmed.2022.1093329 |
Ejemplares similares
-
Role of the microbiome in essential metabolism in the human gut and its implications for Clostridioides difficile infection
por: Chopra, Teena, et al.
Publicado: (2023) -
Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls
por: Sandhu, Avnish, et al.
Publicado: (2021) -
Two-year durability of REBYOTA™ (RBL), a live biotherapeutic for the prevention of recurrent Clostridioides difficile infections
por: Orenstein, Robert, et al.
Publicado: (2023) -
Insights into the Role of Human Gut Microbiota in Clostridioides difficile Infection
por: Kachrimanidou, Melina, et al.
Publicado: (2020) -
Gut Microbiota Composition Associated with Clostridioides difficile Colonization and Infection
por: Martinez, Elisa, et al.
Publicado: (2022)